DIMED (PNVL3) Main Indicators
Basic Data - PNVL3
| Company | DIMED |
| Corporate Name | DIMED S.A. DISTRIBUIDORA DE MEDICAMENTOS |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Comercio atacadista e varejista de medicamentos e produtos de perfumaria e toucador |
| Share | PNVL3 |
| Quote Date | 04/01/2025 |
| Share Type | ON |
| Last Closing | R$ 8.74 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 2.93 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 04/02/2025 | |
Relative Prices - PNVL3
| Price/Earnings | 12.46 |
| Price/SBV | 1.06 |
| Price/Net Sales | 0.27 |
| Price/CFO | 5.86 |
| Price/FCF | 12.92 |
| Price/Total Assets | 0.39 |
| Price/EBIT | 6.73 |
| Price/Working Capital | 1.59 |
| Price/NCAV | -1.00 |
| EV/EBIT | 12.65 |
| EV/EBITDA | 6.09 |
| EV/Net Sales | 0.50 |
| EV/CFO | 11.01 |
| EV/FCF | 24.28 |
| EV/Total Assets | 0.73 |
| Company Market Cap | R$ 1.31 B |
| Enterprise Value | R$ 2.47 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 8.74 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 4.84% |
| Updated 04/02/2025 | |
Income Statement - PNVL3
| Net Revenue | R$ 4.94 B |
| Gross Result | R$ 1.57 B |
| EBIT | R$ 195.28 M |
| Depreciation and Amortization | - R$ 210.16 M |
| EBITDA | R$ 405.44 M |
| Net Profit | R$ 105.51 M |
| Net Profit/Share | R$ 0.70 |
| Updated 03/27/2025 | |
| Net Revenue | R$ 1.35 B |
| Gross Result | R$ 423.80 M |
| EBIT | R$ 58.81 M |
| Depreciation and Amortization | - R$ 54.65 M |
| EBITDA | R$ 113.46 M |
| Net Profit | R$ 30.97 M |
| Profit/Share | R$ 0.21 |
| Updated 03/27/2025 | |
Price and Volume Behavior - PNVL3
| Lowest Price 52 weeks | R$ 7.81 |
| Highest Price 52 weeks | R$ 12.28 |
| Variation 2025 | 2.66% |
| Variation 1 year | -22.67% |
| Variation 2 years(total) | -3.47% |
| Variation 2 years(yearly) | -1.74% |
| Variation 3 years(total) | -33.50% |
| Variation 3 years(yearly) | -12.70% |
| Variation 4 years(total) | -49.90% |
| Variation 4 years(yearly) | -15.86% |
| Variation 5 years(total) | -56.38% |
| Variation 5 years(yearly) | -15.28% |
| Average Daily Volume (3 months) | R$ 2.06 M |
| Updated 04/02/2025 | |
Returns and Margins - PNVL3
| Return on Initial Tangible Capital | 6.14% |
| Return on Initial Invested Capital | 5.94% |
| Pre-Tax Return on Initial Tangible Capital | 9.30% |
| Pre-Tax Return on Initial Invested Capital | 9.01% |
| Return on Initial Shareholder´s Equity | 8.99% |
| Return on Initial Asset | 3.43% |
| Gross Margin | 31.79% |
| Net Margin | 2.13% |
| EBIT Margin | 3.95% |
| EBITDA Margin | 8.20% |
| Initial Asset Turnover | 1.61 |
| Financial Leverage | 2.74 |
| Liabilities/Net Worth | 1.74 |
| Net Debt/EBITDA | 2.85 |
| Updated 03/27/2025 | |
Balance Sheet - PNVL3
| Cash and Cash Equivalents | R$ 80.00 M |
| Total Assets | R$ 3.38 B |
| Short-Term Debt | R$ 292.73 M |
| Long-Term Debt | R$ 943.08 M |
| Gross Debt | R$ 1.24 B |
| Net Debt | R$ 1.16 B |
| Shareholder´s Equity | R$ 1.23 B |
| Share Book Value | R$ 8.21 |
| Common Shares | 150,377,841 |
| Preferred Shares | 0 |
| Total | 150,377,841 |
| Common Shares in Treasury | 1,584,230 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,584,230 |
| Common Shares (Except Treasury) | 148,793,611 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 148,793,611 |
| Updated 03/27/2025 | |
Cash Flow - PNVL3
| Operating Cash Flow | R$ 224.45 M |
| Cash Flow from Investments | - R$ 55.69 M |
| Financing Cash Flow | - R$ 116.71 M |
| Increase (Reduction) in Cash and Equivalents | R$ 52.04 M |
| Updated 03/27/2025 | |
| Operating Cash Flow | R$ 76.86 M |
| Cash Flow from Investments | R$ 2.10 M |
| Financing Cash Flow | - R$ 11.14 M |
| Increase (Reduction) in Cash and Equivalents | R$ 67.82 M |
| Updated 03/27/2025 | |
Experimental - PNVL3
| CAPEX 3 months | - R$ 40.52 M |
| Free Cash Flow 3 months | R$ 36.34 M |
| CAPEX 12 months | - R$ 122.72 M |
| Free Cash Flow 12 months | R$ 101.73 M |
| Updated 03/27/2025 | |